Role of Hepatic Venous Pressure Gradient as a predictor of response to Endoscopic Variceal Ligation in patients of Cirrhosis with Esophageal varices

Title: Role of Hepatic Venous Pressure Gradient as a predictor of response to Endoscopic Variceal Ligation in patients of Cirrhosis with Esophageal varices

Authors: Gul Javid, Ghulam Mohd Gulzar, Shoib Mohd Patto, Mohd Sultan Alie, Showkat Ali Zargar

DOI: http://dx.doi.org/10.18535/jmscr/v3i9.28

Abstract

References

Corresponding Author

Abstract

Background: Portal hypertension is a major consequence of cirrhosis characterized by life threatening variceal bleeding. Estimation of Hepatic venous pressure gradient (HVPG) is the gold standard for diagnosing portal hypertension. Advances in endoscopic treatment have improved survival rates.

Objective: Assessment of HVPG as a predictor of response to endoscopic variceal ligation (EVL) in patients of cirrhosis with esophageal varices.

Material and Methods: HVPG was measured in 40 consecutive cirrhotic patients, 26 had history of variceal bleeding, 27 were males and mean age was 51.05±9.99 years. All patients received EVL until variceal eradication.

Results: Ten patients had HVPG ≤ 12 mmHg, 11 patients had 13 -15 mmHg, 10 patients had 16-18 mmHg and 9 patients had > 18 mmHg. . Mean number of EVL sessions required for variceal eradication in patients with HVPG ≤ 12, 13-15, 16-18 and >18 mmHg were 2.10, 2.64, 4.10, 5.33 respectively. A significantly positive correlation was found between the levels of HVPG and number of EVL sessions required for variceal eradication (correlation coefficient of 0.844, regression coefficient of 0.344). Patients requiring more number of EVL sessions had significantly (p<0.001) higher mean HVPG levels ascompared to patients requiring less number of EVL sessions. Post hoc analysis on pair wise comparison shows that as HVPG rises, there is significant increase (p<0.001) in number of EVL sessions required for variceal eradication.

Conclusion: HVPG has a significant influence on response to EVL, in terms of number of sessions required for variceal eradication.

Key Words: Cirrhosis, portal hypertension, HVPG, Varices, EVL, Variceal obliteration.

References

1. Boyer TD, Triger DR, Horisawa M, Redeker AG, Reynolds TB. Direct transhepatic measurement of portal vein pressure using a thin needle. Comparison with wedged hepatic vein pressure. Gastroenterology 1977: 72:584 –589.

2. Lin HC, Tsai YT, Lee FY, Chang TT, Wang SS, Lay CS, Lee SD, Lo KJ. Comparison between portal vein pressure and wedged hepatic vein pressure in hepatitis B-related cirrhosis. J Hepatol 1989:9:326 –330

3. Perello A, Escorell A, Bru C, Gilabert R, Moitinho E, Garcia-Pagan JC, Bosh J. Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis. Hepatology 1999:30:1393–1397

4. Groszmann RJ, Bosch J, Grace ND, Conn HO, Garcia-Tsao G, Navasa M, Alberts J, Rodes J, Fischer R, Bermann M, Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990:99:1401-140.

5. Viallet A, Marleau D, Huet PM, Martin F, Farley A, Villeneuve JP, Lavoi P. Hemodynamic evaluation of patients with intrahepatic portal hypertension. Relationship between bleeding varices and the porto- hepatic gradient. Gastroenterology 1975:69:1297–1300.

6. Lebrec D, De Fleury P, Rueff B, Nahum H, Benhamou JP. Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology 1980: 79:1139 –1144.

7. Wadhawan M, Dubey S, Sharma BC, Sarin SK. Hepatic venous pressure gradient in cirrhosis: correlation with the size of varices, bleeding ascites and Child’s status. Dig Dis Sci 2006: 51:2264–2269

8. Suk KT, Kim CH,Park SH, Sung HT, Choi YJ, Han KH, Hong SH, Kim DY, Yoon JH, Kim YS, Baik GH, Kim JB, Kim DJ. Comparison of Hepatic venous pressure gradient and two models of end stage liver disease for predicting the survival in patients with decompensated liver cirrohosis. J Clin Gastroenterol 2012: 46:880-886

9. Ripoll C, Bañares R, Rincon D, Catalina MV, Lo Iacono O, Salcedo M, Clemente G, Nunez, Matilla A, Molinero LM. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era. Hepatology 2005:42:793-801

10. Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, Escorsell A, Garcia-Pagan JC, Patch D, Matloff DS, Gao H, Makuch R. for the Portal Hypertension Collaborative Group. Beta blockers to prevent gastro esophageal varices in patients with cirrhosis. N Engl J Med 2005 : 353:2254-2261

11. Kim MY. Pathophysiology and diagnosis of portal hypertension. Korean J Med 2008: 75:1-5.

12. Merkel C, Bolognesi M, Bellon S, Zuin R, Noventa F, Finucci G, Sacerdoti D, Angeli P, Gatta A. Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices. Gastroenterology 1992:102:973-979

13. Gulzar GM , ZargarSA ,Sheikh J, AlaieMS, Javid G, Suri P K ,Shah NA, Bilal-Ul-Rehman, Hakeem MS, Shoukat A, Dar GA. Correlation of hepatic venous pressure gradient with variceal bleeding, size of esophageal varices, etiology, ascites and degree of liver dysfunction in cirrhosis of liver. Indian J Gastroenterol 2009(March–April):28 (2):59–61.

14. Silkauskaite V, Pranculis A, Mitraite D, Jonaitis L, Petrenkiene V, KupcinskasL Hepatic venous pressure gradient measurement in patients with liver cirrhosis: a correlation with disease severity and variceal bleeding.Medicina (Kaunas) 2009: 45(1):8-13.

15. Burroughs AK, Jenkins WJ, Sherlock S, Dunk A, Walt RP, Osuafor TO, Mackie S, Dick R Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med 1983: 309:1539 –1542.

16. Villeneuve JP, Pomier-Layrargues G, Infante-Rivard C, Willems B, Huet PM, Marleau D, Viallet A A. Propranolol for the prevention of recurrent variceal hemorrhage: a controlled trial. Hepatology 1986: 6:1239 –1243.

17. Groszmann RJ, Bosch J, Grace ND, Conn HO, Garcia-Tsao G, Navasa M , Alberts J, Rodes J, Fischer R, Bermann M. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990: 99:1401–1407.

18. Feu F, Garcia-Pagan JC, Bosch J, Luca A, Teres J, Escorsell A .Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995: 346:1056 –1059

19. Suk KT. Hepatic venous pressure gradient: clinical use in chronic liver disease Clin Mol Hepatol 2014:20(1):6-14

20. DeFranchisR.Revising consensus in portal hypertension: report of Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension.J Heptol 2010: 53:762-768.

21. Pugh RNH,Murray-Lyon IM,DawsonJL, PietroniMC,WilliamsR.Transection of the oesophagus for bleeding esophageal varices.Br J Surg 1973:60:646-649

22 Zargar SA,Javid G,Khan BA,Yatto GN, Shah AH, Gulzar GM, Sing J,Rehman B,Din Z.Endoscopic ligation compared with seclerotherapy for bleeding esophageal varices in children with extrahepatic portal vein obstruction. Hype-rtension. Hepatology 2002: 36:666-672.

23 Keppel G&Wickens, T.D. Design and analysis: A researchers handbook (4^th Edition) (2004). Upper Saddle River, NJ: Pearson. Prentice Hall.

24 Patch D, Armonis A, Sabin C, K Christopoulou, L Greenslade, A McCormick, R Dick, A K Burroughs.Single portal pressure measurement predicts survival in cirrhotic patients with recent bleeding. Gut 1999:44:264–9.

25 Pemier-Layrargues G, Kusielewitcz D, Willems B, Villeneuve JP, Marleau D, Cote J, Huet PM.Presinusoidal portal hypertension in non-alcoholic cirrhosis. Hepatology1985:5:415–8.

26 Triantos CK,Goulis J,Patch D, Papatheodoridis GV,Leandro G, Samonakis D,Chologitas E,Bourroughs AK .An evaluation of emergency sclerotherapy of varices in a randomized trail looking for the needle in the eye. Endoscopy 2006:38:797-807 30

27 D’Amico G, Garcia-Pagan JC, Luca A, BoschJ. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology 2006:131:1611-1624.

28 Feu F, Garcia-Pagan JC, Bosch J, Luca A, Teres J, Escorsell A, Rodes J. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995:346:1056-1059.

29 Merkel C, Bolognesi M, Bellon S, Zuin R, Noventa F, Finucci G, et al. Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices. Gastroenterology 1992:102:973-979.

30 Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrohosis. Hepatology 2007:46:922-938.

31 Sarin SK, Wadhawan R, Agerwal SR, Tyagi P, Sharma BC.Endoscopic variceal ligation plus propanol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding Am J Gastroenterol 2005: 100:797-804.

Abstract

References

Corresponding Author

Call For Paper Volume 12 Issue 12 December 2024

JMSCR Menu

Impact Factor SJIF 2024: 7.892

Crossref - DOI

Editorial Policy

Frequency of Publication

Submission of Articles

Search